Literature DB >> 836729

Improvement of symptoms in patients with sick sinus syndrome by spontaneous development of stable atrial fibrillation.

Z Vera, D T Mason, N A Awan, R R Miller, D Janzen, M J Tonkon, L A Vismara.   

Abstract

Fifty-six patients with symptomatic chronic sinus bradycardia because of sick sinus syndrome (SSS) were followed for periods from one month to 11 years (average 3-2 years). Eleven developed stable atrial fibrillation persisting for 8 to 61 months; 52 had permanent demand pacemakers implanted before atrial fibrillation commenced. In the 11 patients with atrial fibrillation, 10 had adequate ventricular rate, 8 with rates greater than 100 beats/min requiring digoxin for rate control. The 8 patients with atrial fibrillation with pacemakers remained asymptomatic for 13 to 18 months without requiring reimplantation; battery failure occurred in 2 whose rapid ventricular rates were controlled by digoxin. In the other 6 patients with pacemakers who developed atrial fibrillation, adequate ventricular rates persisted resulting in overdrive suppression. No patient had systemic embolisation. The previous duration of symptomatic sinus bradycardia was longer in patients developing atrial fibrillation (average 5-5 years) compared (P less than 0-01) with patients without atrial fibrillation (1-9 years). Further, premature atrial contractions occurred in all 11 patients before atrial fibrillation in contrast to only 21 of the 45 patients without atrial fibrillation. It is concluded that occurrence of atrial fibrillation in SSS with symptomatic sinus bradycardia provides a natural cure of symptoms caused by bradycardia. These data indicate that permanent ventricular pacing may not be necessary if persistent atrial fibrillation develops in SSS.

Entities:  

Mesh:

Year:  1977        PMID: 836729      PMCID: PMC483210          DOI: 10.1136/hrt.39.2.160

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  9 in total

1.  The syndrome of alternating bradycardia and tachycardia.

Authors:  D S SHORT
Journal:  Br Heart J       Date:  1954-04

2.  Permanent pacing in disorders of sinus node function.

Authors:  V Krishnaswami; A R Geraci
Journal:  Am Heart J       Date:  1975-05       Impact factor: 4.749

Review 3.  The sick sinus syndrome.

Authors:  M I Ferrer
Journal:  Circulation       Date:  1973-03       Impact factor: 29.690

4.  Premature atrial stimulation as a key to the understanding of sinoatrial conduction in man. Presentation of data and critical review of the literature.

Authors:  H C Strauss; A L Saroff; J T Bigger; E G Giardina
Journal:  Circulation       Date:  1973-01       Impact factor: 29.690

5.  Clinical spectrum of the sick sinus syndrome.

Authors:  J J Rubenstein; C L Schulman; P M Yurchak; R W DeSanctis
Journal:  Circulation       Date:  1972-07       Impact factor: 29.690

6.  The sick sinus syndrome in atrial disease.

Authors:  M I Ferrer
Journal:  JAMA       Date:  1968-10-14       Impact factor: 56.272

7.  Atrial ectopic activity associated with sinus bradycardia.

Authors:  B G Goel; J Han
Journal:  Circulation       Date:  1970-11       Impact factor: 29.690

8.  Chest wall stimulation in evaluation of patients with implanted ventricular-inhibited demand pacemakers.

Authors:  S S Barold; G A Pupillo; J J Gaidula; J W Linhart
Journal:  Br Heart J       Date:  1970-11

9.  Evaluation of sino-atrial node function in man by overdrive suppression.

Authors:  W Mandel; H Hayakawa; R Danzig; H S Marcus
Journal:  Circulation       Date:  1971-07       Impact factor: 29.690

  9 in total
  2 in total

1.  Prevalence of atrial fibrillation and stroke in paced patients without prior atrial fibrillation: a prospective study.

Authors:  A V Mattioli; E T Castellani; D Vivoli; F A Sgura; G Mattioli
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

2.  Electrophysiological and haemodynamic basis for application of new pacemaker technology in sick sinus syndrome and atrioventricular block.

Authors:  R Sutton; P Citron
Journal:  Br Heart J       Date:  1979-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.